The proton pump inhibitor, lansoprazole, inhibits rhinovirus infection in the cultured human tracheal epithelial cells

T. Sasaki, H. Yasuda, D. Inoue, T. Nukiwa, M. Yamaya (Sendai, Japan)

Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Session: Influenza A (H1N1) and other viral infections: therapeutic aspects
Session type: Thematic Poster Session
Number: 2988
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Sasaki, H. Yasuda, D. Inoue, T. Nukiwa, M. Yamaya (Sendai, Japan). The proton pump inhibitor, lansoprazole, inhibits rhinovirus infection in the cultured human tracheal epithelial cells. Eur Respir J 2010; 36: Suppl. 54, 2988

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An inhibitor of HMG-CoA reductase, pitavastatin, inhibits rhinovirus infection in human tracheal epithelial cells
Source: Annual Congress 2009 - Lung cell biology and immunology
Year: 2009


Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells
Source: Eur Respir J 2006; 28: 51-58
Year: 2006



Effect of roflumilast, a PDE4 inhibitor, on ciliary beat frequency in human nasal epithelial cells
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008

Effect of clarithromycin on rhinovirus-16 infection in A549 cells
Source: Eur Respir J 2006; 27: 12-19
Year: 2006



Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF-β in primary cultures of human bronchial epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 394s
Year: 2003

Effects of the PDE4 inhibitor roflumilast n-oxide on the adherence of polymorphonuclear cells (PMNC) to bronchial epithelial cells (BEAS-2B) induced by non-typeable Haemophilus influenzae
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009


Roflumilast N-oxide (RNO) alleviates from RSV-induced loss of ciliated cells and enhanced MUC5AC in differentiated human bronchial epithelial cells (D-HBE)
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

The PDE4 inhibitor roflumilast N-oxide partly restored cigarette smoke (CS)-induced tight junction disassembly in human airway epithelial cells (Calu-3) – role of MAPK
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008

Physiomer(R) reduces the chemokine interleukin-;8 production by activated human respiratory epithelial cells
Source: Eur Respir J 2001; 18: 661-666
Year: 2001



Induction of apoptosis in murine alveolar epithelial cells by a proteasome inhibitor
Source: Eur Respir J 2001; 18: Suppl. 33, 358s
Year: 2001

Human airway trypsin-like protease stimulates differentiation of fibroblasts to myofibroblasts in human bronchial fibroblasts in vitro
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018


Simvastatin selectively inhibits TSLP-production in primary bronchial epithelial cells from COPD donors
Source: Annual Congress 2011 - Translational models of disease
Year: 2011

Effect of roflumilast N-oxide on non-typable haemophilus influenzae (NTHi) interaction with human airway epithelial A549 cells
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011


PUR1800 (RV1162), A novel narrow spectrum kinase inhibitor, but not Fluticasone, reduces TNFa-induced cytokine release by primary bronchial epithelial cells from healthy volunteers and COPD patients
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018



The PDE4 inhibitor roflumilast N-oxide partly reversed TGFß1-induced changes in collagen I and E-cadherin expression in human airway epithelial cells
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008

Adenovirus E1A suppressed elafin secretion in human bronchial epithelial cells and alveolar epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 554s
Year: 2004

Inhibition of Pim1 kinase reduces viral replication in primary bronchial epithelial cells
Source: Eur Respir J 2015; 45: 1745-1748
Year: 2015


LATE-BREAKING ABSTRACT: Effects of a single treatment with PC786, a novel inhibitor of respiratory syncytial virus replication, on viral load and biomarkers in fully differentiated human bronchial epithelial cells
Source: International Congress 2016 – Translational research in respiratory infections
Year: 2016


Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells
Source: Eur Respir J 2012; 40: 122-132
Year: 2012



Adenoviral infection does not increase β-defensin1-3 and RNAse7 mRNA levels in A549 cells and respiratory epithelial cell cultures derived from human adenoids and human bronchial biopsies
Source: Eur Respir J 2006; 28: Suppl. 50, 563s
Year: 2006